Loading...
Developing preclinical models of neuroblastoma: driving therapeutic testing
Despite advances in cancer therapeutics, particularly in the area of immuno-oncology, successful treatment of neuroblastoma (NB) remains a challenge. NB is the most common cancer in infants under 1 year of age, and accounts for approximately 10% of all pediatric cancers. Currently, children with hig...
Na minha lista:
| Udgivet i: | BMC Biomed Eng |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7422585/ https://ncbi.nlm.nih.gov/pubmed/32903387 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42490-019-0034-8 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|